sFlt-1 Levels in Early Pregnancy and Pregnancy Outcomes
Author Information
Author(s): Marni Jacobs, Natasha Nassar, Christine L Roberts, Ruth Hadfield, Jonathan M Morris, Anthony W Ashton
Primary Institution: University of Sydney, Royal North Shore Hospital
Hypothesis
Are levels of sFlt-1 in early pregnancy associated with adverse pregnancy outcomes?
Conclusion
This review found no clear evidence of an association between sFlt-1 levels in the first trimester and adverse pregnancy outcomes.
Supporting Evidence
- Levels of sFlt-1 were generally higher among women who developed preeclampsia.
- Most studies did not find significant differences in sFlt-1 levels between normotensive and hypertensive women.
- Variability in sFlt-1 concentrations was observed across different studies.
Takeaway
The study looked at a protein called sFlt-1 in pregnant women to see if it could predict problems during pregnancy, but it didn't find strong evidence that it could.
Methodology
A systematic review of studies assessing sFlt-1 levels in the first trimester and their association with pregnancy complications.
Potential Biases
Differences in participant characteristics and exclusion criteria across studies may introduce bias.
Limitations
Variations in study design, sample types, and outcome definitions limited the ability to pool results.
Participant Demographics
Pregnant women in their first trimester, with varying health backgrounds.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website